SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-022623
Filing Date
2024-03-14
Accepted
2024-03-14 16:28:24
Documents
18
Period of Report
2024-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201825-8k_unicycive.htm   iXBRL 8-K 51285
2 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF THE SERIES ea020182501ex3-1_unicycive.htm EX-3.1 105734
3 SECURITIES PURCHASE AGREEMENT, DATED MARCH 13, 2024, BY AND BETWEEN UNICYCIVE TH ea020182501ex10-1_unicycive.htm EX-10.1 333122
4 PRESS RELEASE DATED MARCH 14, 2024 ea020182501ex99-1_unicycive.htm EX-99.1 16734
5 GRAPHIC ex99-1_001.jpg GRAPHIC 8429
  Complete submission text file 0001213900-24-022623.txt   805876

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE uncy-20240313.xsd EX-101.SCH 3018
7 XBRL LABEL FILE uncy-20240313_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE uncy-20240313_pre.xml EX-101.PRE 22361
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0201825-8k_unicycive_htm.xml XML 3818
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40582 | Film No.: 24750600
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)